NASDAQ:SIGA - US8269171067 - Common Stock
Overall SIGA gets a fundamental rating of 8 out of 10. We evaluated SIGA against 193 industry peers in the Pharmaceuticals industry. Both the health and profitability get an excellent rating, making SIGA a very profitable company, without any liquidiy or solvency issues. SIGA is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make SIGA a good candidate for value and quality investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 34.92% | ||
ROE | 39.26% | ||
ROIC | 36.93% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 56.25% | ||
PM (TTM) | 45.75% | ||
GM | 76.92% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 16.61 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 10.09 | ||
Quick Ratio | 8.52 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.27 | ||
Fwd PE | 5.06 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 4.94 | ||
EV/EBITDA | 3.99 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 6.57% |
8.21
-0.04 (-0.48%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 6.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.27 | ||
Fwd PE | 5.06 | ||
P/S | 3.27 | ||
P/FCF | 4.94 | ||
P/OCF | 4.94 | ||
P/B | 2.81 | ||
P/tB | 2.82 | ||
EV/EBITDA | 3.99 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 34.92% | ||
ROE | 39.26% | ||
ROCE | 47.53% | ||
ROIC | 36.93% | ||
ROICexc | 260.41% | ||
ROICexgc | 268.41% | ||
OM | 56.25% | ||
PM (TTM) | 45.75% | ||
GM | 76.92% | ||
FCFM | 66.25% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 12.22% | ||
Cap/Sales | 0.04% | ||
Interest Coverage | 250 | ||
Cash Conversion | 117.21% | ||
Profit Quality | 144.82% | ||
Current Ratio | 10.09 | ||
Quick Ratio | 8.52 | ||
Altman-Z | 16.61 |